薑黃素文獻薈萃報告 — 2026 年 4 月

摘要

本月共收錄 薑黃素 相關文獻 1619 篇,其中 Level 1 證據(Meta-Analysis/Systematic Review)86 篇,RCT 12 篇。

證據等級分布

證據等級 文獻數 佔比
Level 1 (Meta-Analysis/Systematic Review) 86 5.3%
Level 2 (RCT) 12 0.7%
Level 3 (Clinical Trial) 3 0.2%
Level 4 (Observational) 3 0.2%
Level 5 (Review/Case Report/Other) 1515 93.6%

功效分類統計

功效分類 中文 文獻數 佔比
immune 免疫調節 765 47.3%
other 其他 475 29.3%
metabolic 代謝 239 14.8%
cardiovascular 心血管 235 14.5%
digestive 消化 200 12.4%
cognitive 認知功能 185 11.4%
anti_aging 抗衰老 168 10.4%
musculoskeletal 肌肉骨骼 148 9.1%
skin 皮膚 113 7.0%
energy 活力 60 3.7%
sexual 性功能 25 1.5%

成分搭配統計

成分 文獻數
curcumin 1340
EPA 288
iron 233
turmeric 223
resveratrol 186
quercetin 118
EGCG 48
berberine 48
stem cell 47
hyaluronic acid 39

成分組合分析

以下列出最常被共同研究的成分組合:

成分組合 共同出現文獻數
EPA + curcumin 250
curcumin + iron 203
curcumin + resveratrol 185
curcumin + turmeric 118
curcumin + quercetin 117
quercetin + resveratrol 77
EPA + iron 55
berberine + curcumin 48
curcumin + stem cell 45
EGCG + curcumin 45

成分功效分析

以下列出主要成分在各功效領域的研究文獻數:

成分 總文獻 免疫調節 其他 代謝 心血管 消化 抗衰老
curcumin 1340 687 351 210 206 169 144
EPA 288 139 73 48 52 39 35
iron 233 121 57 32 41 19 30
turmeric 223 92 76 45 34 29 18
resveratrol 186 133 26 46 42 31 42
quercetin 118 73 23 29 22 14 26
EGCG 48 24 15 10 4 7 6
berberine 48 36 9 15 9 11 9

研究類型分布

研究類型 文獻數 佔比
Meta-Analysis 45 2.8%
Systematic Review 41 2.5%
RCT 12 0.7%
Clinical Trial 3 0.2%
Observational 3 0.2%
Review 212 13.1%
Case Report 2 0.1%
Other 1301 80.4%

近期重要文獻

Level 1 證據(Meta-Analysis / Systematic Review)

  1. Research progress of curcumin and its derivatives as anti-inflammatory agents: From molecular mechanism to clinical application. — European journal of medicinal chemistry,
    • 功效分類:cognitive, immune
  2. Antidiabetic and Metabolic Effects of Turmeric (Curcuma Longa) in Patients with Type 2 Diabetes Mellitus or Hyperglycemia - A Systematic Meta-Review and Meta-Analysis. — Journal of Nepal Health Research Council,
    • 功效分類:anti_aging, cardiovascular, metabolic
  3. Levodopa and Plant-Derived Bioactive Compounds in Parkinson’s Disease: Mechanisms, Efficacy, and Future Perspectives. — CNS neuroscience & therapeutics, 2025-08-01
    • 功效分類:cognitive, immune, skin
  4. Analgesic Efficacy of Phytotherapeutic Agents in Dental Pain Management: A Systematic Review. — International journal of dentistry,
    • 功效分類:other
  5. Effectiveness of 0.1% triamcinolone acetonide compared with those of other therapies for minor recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials. — BMC oral health,
    • 功效分類:other

Level 2 證據(RCT)

  1. Effects of Maternal Curcumin Nano-Micelle Supplementation on Ewes and Their Offspring: Impact on Nutrient Digestibility, Ruminal Fermentation Parameters, Milk Composition and Metabolic Health During the Transition Period. — Journal of animal physiology and animal nutrition, 2025-11-01
    • 功效分類:cardiovascular, metabolic
  2. A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19. — Scientific reports, 2025-08-21
    • 功效分類:immune
  3. Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects. — Nutrients, 2025-08-14
    • 功效分類:cardiovascular, immune
  4. A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults. — Journal of the International Society of Sports Nutrition, 2025-12-01
    • 功效分類:immune, musculoskeletal
  5. The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial. — Nutrition journal, 2025-07-18
    • 功效分類:cardiovascular, immune, metabolic

免責聲明

本網站內容由 AI 自動生成,基於各國官方公開資料庫的產品登記資訊。 報告內容僅供參考,不構成醫療建議、投資建議或商業建議。 如有健康問題,請諮詢專業醫療人員。

產品統計以資料庫登記為準,不代表實際市場銷售狀況。 各國監管制度不同,跨國比較應考慮法規差異。


Copyright © 2026 保健食品產品情報系統

This site uses Just the Docs, a documentation theme for Jekyll.